Article
Therapeutic targeting of cancers with loss of PTEN function.
Current drug targets - 1 Jan 2014
Dillon Lloye M, Miller Todd W
Abstract excerpt
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is one of the most frequently disrupted tumor suppressors in cancer. The lipid phosphatase activity of PTEN antagonizes the phosphatidylinositol 3-kinase (PI3K)/AKT/mTOR pathway to repress tumor cell growth and survival. In the nucleus, PTEN promotes chromosome stability and DNA repair. Consequently, loss of PTEN function increases genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
